Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-22

Clinical Trial Update: Uterine Artery Embolization and Pelvic Floor Symptoms

View source ↗

Summary

A clinical trial evaluating uterine artery embolization for uterine fibroids and related pelvic floor symptoms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Leiomyoma, Incontinence | Status: WITHDRAWN